Replies to post #487866 on Anavex Life Sciences Corp (AVXL)

[LakeshoreLeo1953]

Battle George over his being the spokesperson for $2K/year.

[Investor2014]

Yes sounds more realistic and like a good business than treating the A2-73 pill as if it only represents the commodities its is made from plus some small markup.

I can't imagine any business that expect to be around in years to come would adopt the George Bot approach to pricing the fruits of their risky investment and resources.

[boi568]

If blarcamesine is the disease modifying drug we believe it to be, the market will enlarge as the number of AD survivors grow. So that 4M estimate would move upwards, depending on just how effective the drug may be in extending the time of early AD. (Not to mention off-label possibilities, such as MCI [a very large population], PD and other neuro diseases.)